// SCORE BREAKDOWN
Accessible pharma industry glossary for non-specialists; fills knowledge gap with 499 well-written reference entries.
// ABOUT
JB Pharma is a generalist's reference for the language of pharmaceuticals and healthcare — the jargon you encounter in news, earnings calls, regulatory filings, and conferences. 499 entries across the categories that move the industry: regulatory (FDA, IRA, breakthrough therapy), commercial and access (340B, PBM, patent cliff), mechanism (ADC, CAR-T, GLP-1 agonist), and the foundational biology and chemistry every reader needs (DNA, gene therapy, monoclonal antibody, ATP). Every entry is written for orientation — a one-sentence editorial lede, then a few paragraphs of useful context drawing from FDA, NIH, NCI, and other authoritative sources. Cross-references throughout the text mean reading one entry naturally leads to another. Tap a linked term to jump straight to it. Filter by indication, category, or by curated lenses — Policy for the regulatory and access stack, Basics for the foundational biology. Star anything you want to remember; share favorites by email or message. Designed for fast lookup during a meeting, deep reading on a flight, or background context for whatever pharma headline just crossed your feed. No accounts, no tracking, no data collection. Everything stays on your device. JB Pharma is reference material, not medical advice.